Header

BUY LIFE SCIENCE REPORTS

PharmaVision offers a comprehensive choice of high quality, insightful reports which identify key trends, future innovations, and growth opportunities. Our reports cover the life science arena including pharmaceuticals, healthcare, diagnostics, drug delivery, emerging R&D technologies and consumer nutrition.

FEATURED REPORT

Featured Reports Icon

Orphan Drugs: Strategic Approaches for the Industry

The FDA has approved the first treatment for Duchenne muscular dystrophy (DMD), Sarepta's eteplirsen [brand name Exondys 51]. The approval overrules the scientific advisory boards' recommendation against approval following a vote of 7-6 in April due to poor clinical trial designs.

FREE WHITE PAPER

Free White Paper

Factors Currently Diving Pharmaceutical Growth in the Middle East

During the last decade the pharmaceutical industry has been looking towards the emerging economies to expand its global footprint and drive future growth. This white paper focuses on the potential opportunities for investment in the Middle East, particularly with respect to Bahrain, Saudi Arabia and the United Arab Emirates.

EVENTS 2016

Events Icon

14th Annual Pharmaceutical IT Congress

28th Sep 2016 - 29th Sep 2016